Sanofi CEO can’t sugar-coat ‘shocking’ Q2 results

Tracy Staton Call it what you will: chutzpah, optimism, wishful thinking, spin-doctoring, or just plain confidence. In any case, the headline on Sanofi's earnings release–"Last ...

Gist of AstraZeneca’s Q2 results: It could have been worse

Tracy Staton A few high notes in its second-quarter report — notably growth in China and an increase in Brilinta sales–give some support to CEO Pascal Soriot's attempts ...

McKesson Shareholders Vote In Favor Of A Clawback Policy

esilverman Shareholders for McKesson, one of the largest pharmaceutical wholesalers in the US, voted in favor of instituting a clawback policy that was proposed by two institutional ...

Buzz: Hungry AstraZeneca circles a blockbuster biosimilars buyout

John Carroll Quoting sources close to the deal, Korea's Financial News says that Celltrion hooked AstraZeneca's interest after it began to cast around for a merger deal a few ...

Merck 2Q Profit Drops

barbara.lempert Merck Announces Second-Quarter 2013 Financial Results •2013 Second-Quarter Non-GAAP EPS of $ 0.84, Excluding Certain Items; GAAP EPS of $ 0.30 •Worldwide ...

McKesson Fights A Clawback Policy Proposed By Big Investors

esilverman Should one of the largest drug wholesalers have a clawback policy for executives? Two institutional investors believe the notion is overdue for McKesson, since the ...

Cubist splurges on Trius and Optimer buyouts to spur antibiotics growth

Ryan McBride Cubist Pharmaceuticals surprised some analysts with the announcements of two major acquisitions Tuesday afternoon, agreeing to buy both Trius Therapeutics and Optimer Pharmaceuticals ...

PhRMA, A Congresswoman And A Flap Over Campaign Finance Rules

esilverman Did a congresswoman violate campaign laws by enlisting campaign help from PhRMA? That question is being asked after a senior aide to Colleen Hanabusa, a Democrat ...

Valeant to Cut Jobs, Move Bausch + Lomb HQ

barbara.lempert NEW YORK (AP) — Valeant says it will eliminate as much as 15 percent of its work force and move Bausch + Lomb’s headquarters to New Jersey as part of ...

Perrigo to buy Elan for $8.6B, seeks tax savings

barbara.lempert DUBLIN, July 29, 2013 (AP) — U.S. drugmaker Perrigo has agreed to buy Ireland’s Elan for $ 8.6 billion in a deal designed to expand overseas and reduce ...

Daiichi Sankyo Expands Drug Discovery Program

barbara.lempert Daiichi Sankyo to Expand Its Collaborative Drug Discovery Program to Germany, Switzerland, and Austria Tokyo, Japan (July 29, 2013) — Daiichi Sankyo Company, ...

Another Pharma Deal Spurred, In Part, By A Lower Irish Tax Rate

esilverman ANOTHER PHARMA DEAL SPURRED, IN PART, BY A LOWER IRISH TAX RATE For the second time in recent weeks, Ireland has figured prominently in an acquisition of one drugmaker by ...
Page 20 of 41« First...10...1819202122...3040...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS